世界のメチルフェニデート市場予測 2020年-2025年

◆英語タイトル:Global Methylphenidate Market Growth 2020-2025
◆商品コード:LPI21MA07944
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年1月
◆ページ数:139
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥417,240見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥625,860見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥834,480見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
LP Information社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

「メチルフェニデートの世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、錠剤、カプセル、その他など、用途別には、注意欠陥多動性障害、ナルコレプシー、その他などに区分してまとめた調査レポートです。メチルフェニデートのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・メチルフェニデートの世界市場概要(サマリー)
・メチルフェニデートの企業別販売量・売上
・メチルフェニデートの企業別市場シェア
・メチルフェニデートの世界市場規模 2015年-2020年:種類別(錠剤、カプセル、その他)
・メチルフェニデートの世界市場規模 2015年-2020年:用途別(注意欠陥多動性障害、ナルコレプシー、その他)
・メチルフェニデートの米州市場規模(アメリカ、カナダ、メキシコなど)
・メチルフェニデートのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・メチルフェニデートの欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・メチルフェニデートの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・メチルフェニデート市場の成長要因・課題・動向
・メチルフェニデートの世界市場予測 2021年-2025年
・メチルフェニデートの米州市場予測(アメリカ、カナダ、メキシコなど)
・メチルフェニデートのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・メチルフェニデートの欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・メチルフェニデートの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・メチルフェニデートの世界市場予測:種類別(錠剤、カプセル、その他)
・メチルフェニデートの世界市場予測:用途別(注意欠陥多動性障害、ナルコレプシー、その他)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Methylphenidate market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Methylphenidate business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Methylphenidate market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Methylphenidate, covering the supply chain analysis, impact assessment to the Methylphenidate market size growth rate in several scenarios, and the measures to be undertaken by Methylphenidate companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Tablet
Capsule
Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Attention deficit hyperactivity disorder
Narcolepsy
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Teva
Sandoz
GSK
Novartis

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Methylphenidate consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Methylphenidate market by identifying its various subsegments.
Focuses on the key global Methylphenidate manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Methylphenidate with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Methylphenidate submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Methylphenidate Consumption 2015-2025
2.1.2 Methylphenidate Consumption CAGR by Region
2.2 Methylphenidate Segment by Type
2.2.1 Tablet
2.2.2 Capsule
2.2.3 Others
2.3 Methylphenidate Consumption by Type
2.3.1 Global Methylphenidate Consumption Market Share by Type (2015-2020)
2.3.2 Global Methylphenidate Revenue and Market Share by Type (2015-2020)
2.3.3 Global Methylphenidate Sale Price by Type (2015-2020)
2.4 Methylphenidate Segment by Application
2.4.1 Attention deficit hyperactivity disorder
2.4.2 Narcolepsy
2.4.3 Other
2.5 Methylphenidate Consumption by Application
2.5.1 Global Methylphenidate Consumption Market Share by Type (2015-2020)
2.5.2 Global Methylphenidate Value and Market Share by Type (2015-2020)
2.5.3 Global Methylphenidate Sale Price by Type (2015-2020)

3 Global Methylphenidate by Company
3.1 Global Methylphenidate Sales Market Share by Company
3.1.1 Global Methylphenidate Sales by Company (2018-2020)
3.1.2 Global Methylphenidate Sales Market Share by Company (2018-2020)
3.2 Global Methylphenidate Revenue Market Share by Company
3.2.1 Global Methylphenidate Revenue by Company (2018-2020)
3.2.2 Global Methylphenidate Revenue Market Share by Company (2018-2020)
3.3 Global Methylphenidate Sale Price by Company
3.4 Global Methylphenidate Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Methylphenidate Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Methylphenidate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Methylphenidate by Regions
4.1 Methylphenidate by Regions
4.2 Americas Methylphenidate Consumption Growth
4.3 APAC Methylphenidate Consumption Growth
4.4 Europe Methylphenidate Consumption Growth
4.5 Middle East & Africa Methylphenidate Consumption Growth

5 Americas
5.1 Americas Methylphenidate Consumption by Countries
5.1.1 Americas Methylphenidate Consumption by Countries (2015-2020)
5.1.2 Americas Methylphenidate Value by Countries (2015-2020)
5.2 Americas Methylphenidate Consumption by Type
5.3 Americas Methylphenidate Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Methylphenidate Consumption by Regions
6.1.1 APAC Methylphenidate Consumption by Regions (2015-2020)
6.1.2 APAC Methylphenidate Value by Regions (2015-2020)
6.2 APAC Methylphenidate Consumption by Type
6.3 APAC Methylphenidate Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Methylphenidate by Countries
7.1.1 Europe Methylphenidate Consumption by Countries (2015-2020)
7.1.2 Europe Methylphenidate Value by Countries (2015-2020)
7.2 Europe Methylphenidate Consumption by Type
7.3 Europe Methylphenidate Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Methylphenidate by Countries
8.1.1 Middle East & Africa Methylphenidate Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Methylphenidate Value by Countries (2015-2020)
8.2 Middle East & Africa Methylphenidate Consumption by Type
8.3 Middle East & Africa Methylphenidate Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Methylphenidate Distributors
10.3 Methylphenidate Customer

11 Global Methylphenidate Market Forecast
11.1 Global Methylphenidate Consumption Forecast (2021-2025)
11.2 Global Methylphenidate Forecast by Regions
11.2.1 Global Methylphenidate Forecast by Regions (2021-2025)
11.2.2 Global Methylphenidate Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Methylphenidate Forecast by Type
11.8 Global Methylphenidate Forecast by Application

12 Key Players Analysis
12.1 Pfizer
12.1.1 Company Information
12.1.2 Methylphenidate Product Offered
12.1.3 Pfizer Methylphenidate Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 Teva
12.2.1 Company Information
12.2.2 Methylphenidate Product Offered
12.2.3 Teva Methylphenidate Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Teva Latest Developments
12.3 Sandoz
12.3.1 Company Information
12.3.2 Methylphenidate Product Offered
12.3.3 Sandoz Methylphenidate Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Sandoz Latest Developments
12.4 GSK
12.4.1 Company Information
12.4.2 Methylphenidate Product Offered
12.4.3 GSK Methylphenidate Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 GSK Latest Developments
12.5 Novartis
12.5.1 Company Information
12.5.2 Methylphenidate Product Offered
12.5.3 Novartis Methylphenidate Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Novartis Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Methylphenidate Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Tablet
Table 5. Major Players of Capsule
Table 6. Major Players of Others
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Methylphenidate Consumption Market Share by Type (2015-2020)
Table 9. Global Methylphenidate Revenue by Type (2015-2020) ($ million)
Table 10. Global Methylphenidate Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Methylphenidate Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Methylphenidate Consumption Market Share by Application (2015-2020)
Table 14. Global Methylphenidate Value by Application (2015-2020)
Table 15. Global Methylphenidate Value Market Share by Application (2015-2020)
Table 16. Global Methylphenidate Sale Price by Application (2015-2020)
Table 17. Global Methylphenidate Sales by Company (2017-2019) (K MT)
Table 18. Global Methylphenidate Sales Market Share by Company (2017-2019)
Table 19. Global Methylphenidate Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Methylphenidate Revenue Market Share by Company (2017-2019)
Table 21. Global Methylphenidate Sale Price by Company (2017-2019)
Table 22. Global Methylphenidate Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Methylphenidate Products Offered
Table 24. Methylphenidate Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Methylphenidate Consumption by Regions 2015-2020 (K MT)
Table 26. Global Methylphenidate Consumption Market Share by Regions 2015-2020
Table 27. Global Methylphenidate Value by Regions 2015-2020 ($ Millions)
Table 28. Global Methylphenidate Value Market Share by Regions 2015-2020
Table 29. Americas Methylphenidate Consumption by Countries (2015-2020) (K MT)
Table 30. Americas Methylphenidate Consumption Market Share by Countries (2015-2020)
Table 31. Americas Methylphenidate Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Methylphenidate Value Market Share by Countries (2015-2020)
Table 33. Americas Methylphenidate Consumption by Type (2015-2020) (K MT)
Table 34. Americas Methylphenidate Consumption Market Share by Type (2015-2020)
Table 35. Americas Methylphenidate Consumption by Application (2015-2020) (K MT)
Table 36. Americas Methylphenidate Consumption Market Share by Application (2015-2020)
Table 37. APAC Methylphenidate Consumption by Countries (2015-2020) (K MT)
Table 38. APAC Methylphenidate Consumption Market Share by Countries (2015-2020)
Table 39. APAC Methylphenidate Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Methylphenidate Value Market Share by Regions (2015-2020)
Table 41. APAC Methylphenidate Consumption by Type (2015-2020) (K MT)
Table 42. APAC Methylphenidate Consumption Market Share by Type (2015-2020)
Table 43. APAC Methylphenidate Consumption by Application (2015-2020) (K MT)
Table 44. APAC Methylphenidate Consumption Market Share by Application (2015-2020)
Table 45. Europe Methylphenidate Consumption by Countries (2015-2020) (K MT)
Table 46. Europe Methylphenidate Consumption Market Share by Countries (2015-2020)
Table 47. Europe Methylphenidate Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Methylphenidate Value Market Share by Countries (2015-2020)
Table 49. Europe Methylphenidate Consumption by Type (2015-2020) (K MT)
Table 50. Europe Methylphenidate Consumption Market Share by Type (2015-2020)
Table 51. Europe Methylphenidate Consumption by Application (2015-2020) (K MT)
Table 52. Europe Methylphenidate Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Methylphenidate Consumption by Countries (2015-2020) (K MT)
Table 54. Middle East & Africa Methylphenidate Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Methylphenidate Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Methylphenidate Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Methylphenidate Consumption by Type (2015-2020) (K MT)
Table 58. Middle East & Africa Methylphenidate Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Methylphenidate Consumption by Application (2015-2020) (K MT)
Table 60. Middle East & Africa Methylphenidate Consumption Market Share by Application (2015-2020)
Table 61. Methylphenidate Distributors List
Table 62. Methylphenidate Customer List
Table 63. Global Methylphenidate Consumption Forecast by Countries (2021-2025) (K MT)
Table 64. Global Methylphenidate Consumption Market Forecast by Regions
Table 65. Global Methylphenidate Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Methylphenidate Value Market Share Forecast by Regions
Table 67. Global Methylphenidate Consumption Forecast by Type (2021-2025) (K MT)
Table 68. Global Methylphenidate Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Methylphenidate Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Methylphenidate Value Market Share Forecast by Type (2021-2025)
Table 71. Global Methylphenidate Consumption Forecast by Application (2021-2025) (K MT)
Table 72. Global Methylphenidate Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Methylphenidate Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Methylphenidate Value Market Share Forecast by Application (2021-2025)
Table 75. Pfizer Product Offered
Table 76. Pfizer Methylphenidate Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 77. Pfizer Main Business
Table 78. Pfizer Latest Developments
Table 79. Pfizer Basic Information, Company Total Revenue (in $ million), Methylphenidate Manufacturing Base, Sales Area and Its Competitors
Table 80. Teva Product Offered
Table 81. Teva Methylphenidate Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 82. Teva Main Business
Table 83. Teva Latest Developments
Table 84. Teva Basic Information, Company Total Revenue (in $ million), Methylphenidate Manufacturing Base, Sales Area and Its Competitors
Table 85. Sandoz Product Offered
Table 86. Sandoz Methylphenidate Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 87. Sandoz Main Business
Table 88. Sandoz Latest Developments
Table 89. Sandoz Basic Information, Company Total Revenue (in $ million), Methylphenidate Manufacturing Base, Sales Area and Its Competitors
Table 90. GSK Product Offered
Table 91. GSK Methylphenidate Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 92. GSK Main Business
Table 93. GSK Latest Developments
Table 94. GSK Basic Information, Company Total Revenue (in $ million), Methylphenidate Manufacturing Base, Sales Area and Its Competitors
Table 95. Novartis Product Offered
Table 96. Novartis Methylphenidate Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 97. Novartis Main Business
Table 98. Novartis Latest Developments
Table 99. Novartis Basic Information, Company Total Revenue (in $ million), Methylphenidate Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Methylphenidate
Figure 2. Methylphenidate Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Methylphenidate Consumption Growth Rate 2015-2025 (K MT)
Figure 5. Global Methylphenidate Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Tablet
Figure 7. Product Picture of Capsule
Figure 8. Product Picture of Others
Figure 9. Global Methylphenidate Consumption Market Share by Type (2015-2020)
Figure 10. Global Methylphenidate Value Market Share by Type (2015-2020)
Figure 11. Methylphenidate Consumed in Attention deficit hyperactivity disorder
Figure 12. Global Methylphenidate Market: Attention deficit hyperactivity disorder (2015-2020) (K MT)
Figure 13. Global Methylphenidate Market: Attention deficit hyperactivity disorder (2015-2020) ($ Millions)
Figure 14. Methylphenidate Consumed in Narcolepsy
Figure 15. Global Methylphenidate Market: Narcolepsy (2015-2020) (K MT)
Figure 16. Global Methylphenidate Market: Narcolepsy (2015-2020) ($ Millions)
Figure 17. Methylphenidate Consumed in Other
Figure 18. Global Methylphenidate Market: Other (2015-2020) (K MT)
Figure 19. Global Methylphenidate Market: Other (2015-2020) ($ Millions)
Figure 20. Global Methylphenidate Consumption Market Share by Application (2015-2020)
Figure 21. Global Methylphenidate Value Market Share by Application (2015-2020)
Figure 22. Global Methylphenidate Sales Market Share by Company in 2017
Figure 23. Global Methylphenidate Sales Market Share by Company in 2019
Figure 24. Global Methylphenidate Revenue Market Share by Company in 2017
Figure 25. Global Methylphenidate Revenue Market Share by Company in 2019
Figure 26. Global Methylphenidate Sale Price by Company in 2019
Figure 27. Global Methylphenidate Consumption Market Share by Regions 2015-2020
Figure 28. Global Methylphenidate Value Market Share by Regions 2015-2020
Figure 29. Americas Methylphenidate Consumption 2015-2020 (K MT)
Figure 30. Americas Methylphenidate Value 2015-2020 ($ Millions)
Figure 31. APAC Methylphenidate Consumption 2015-2020 (K MT)
Figure 32. APAC Methylphenidate Value 2015-2020 ($ Millions)
Figure 33. Europe Methylphenidate Consumption 2015-2020 (K MT)
Figure 34. Europe Methylphenidate Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Methylphenidate Consumption 2015-2020 (K MT)
Figure 36. Middle East & Africa Methylphenidate Value 2015-2020 ($ Millions)
Figure 37. Americas Methylphenidate Consumption Market Share by Countries in 2019
Figure 38. Americas Methylphenidate Value Market Share by Countries in 2019
Figure 39. Americas Methylphenidate Consumption Market Share by Type in 2019
Figure 40. Americas Methylphenidate Consumption Market Share by Application in 2019
Figure 41. United States Methylphenidate Consumption Growth 2015-2020 (K MT)
Figure 42. United States Methylphenidate Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Methylphenidate Consumption Growth 2015-2020 (K MT)
Figure 44. Canada Methylphenidate Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Methylphenidate Consumption Growth 2015-2020 (K MT)
Figure 46. Mexico Methylphenidate Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Methylphenidate Consumption Market Share by Countries in 2019
Figure 48. APAC Methylphenidate Value Market Share by Regions in 2019
Figure 49. APAC Methylphenidate Consumption Market Share by Type in 2019
Figure 50. APAC Methylphenidate Consumption Market Share by Application in 2019
Figure 51. China Methylphenidate Consumption Growth 2015-2020 (K MT)
Figure 52. China Methylphenidate Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Methylphenidate Consumption Growth 2015-2020 (K MT)
Figure 54. Japan Methylphenidate Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Methylphenidate Consumption Growth 2015-2020 (K MT)
Figure 56. Korea Methylphenidate Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Methylphenidate Consumption Growth 2015-2020 (K MT)
Figure 58. Southeast Asia Methylphenidate Value Growth 2015-2020 ($ Millions)
Figure 59. India Methylphenidate Consumption Growth 2015-2020 (K MT)
Figure 60. India Methylphenidate Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Methylphenidate Consumption Growth 2015-2020 (K MT)
Figure 62. Australia Methylphenidate Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Methylphenidate Consumption Market Share by Countries in 2019
Figure 64. Europe Methylphenidate Value Market Share by Countries in 2019
Figure 65. Europe Methylphenidate Consumption Market Share by Type in 2019
Figure 66. Europe Methylphenidate Consumption Market Share by Application in 2019
Figure 67. Germany Methylphenidate Consumption Growth 2015-2020 (K MT)
Figure 68. Germany Methylphenidate Value Growth 2015-2020 ($ Millions)
Figure 69. France Methylphenidate Consumption Growth 2015-2020 (K MT)
Figure 70. France Methylphenidate Value Growth 2015-2020 ($ Millions)
Figure 71. UK Methylphenidate Consumption Growth 2015-2020 (K MT)
Figure 72. UK Methylphenidate Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Methylphenidate Consumption Growth 2015-2020 (K MT)
Figure 74. Italy Methylphenidate Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Methylphenidate Consumption Growth 2015-2020 (K MT)
Figure 76. Russia Methylphenidate Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa Methylphenidate Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa Methylphenidate Value Market Share by Countries in 2019
Figure 79. Middle East & Africa Methylphenidate Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa Methylphenidate Consumption Market Share by Application in 2019
Figure 81. Egypt Methylphenidate Consumption Growth 2015-2020 (K MT)
Figure 82. Egypt Methylphenidate Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa Methylphenidate Consumption Growth 2015-2020 (K MT)
Figure 84. South Africa Methylphenidate Value Growth 2015-2020 ($ Millions)
Figure 85. Israel Methylphenidate Consumption Growth 2015-2020 (K MT)
Figure 86. Israel Methylphenidate Value Growth 2015-2020 ($ Millions)
Figure 87. Turkey Methylphenidate Consumption Growth 2015-2020 (K MT)
Figure 88. Turkey Methylphenidate Value Growth 2015-2020 ($ Millions)
Figure 89. GCC Countries Methylphenidate Consumption Growth 2015-2020 (K MT)
Figure 90. GCC Countries Methylphenidate Value Growth 2015-2020 ($ Millions)
Figure 91. Global Methylphenidate Consumption Growth Rate Forecast (2021-2025) (K MT)
Figure 92. Global Methylphenidate Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 93. Americas Methylphenidate Consumption 2021-2025 (K MT)
Figure 94. Americas Methylphenidate Value 2021-2025 ($ Millions)
Figure 95. APAC Methylphenidate Consumption 2021-2025 (K MT)
Figure 96. APAC Methylphenidate Value 2021-2025 ($ Millions)
Figure 97. Europe Methylphenidate Consumption 2021-2025 (K MT)
Figure 98. Europe Methylphenidate Value 2021-2025 ($ Millions)
Figure 99. Middle East & Africa Methylphenidate Consumption 2021-2025 (K MT)
Figure 100. Middle East & Africa Methylphenidate Value 2021-2025 ($ Millions)
Figure 101. United States Methylphenidate Consumption 2021-2025 (K MT)
Figure 102. United States Methylphenidate Value 2021-2025 ($ Millions)
Figure 103. Canada Methylphenidate Consumption 2021-2025 (K MT)
Figure 104. Canada Methylphenidate Value 2021-2025 ($ Millions)
Figure 105. Mexico Methylphenidate Consumption 2021-2025 (K MT)
Figure 106. Mexico Methylphenidate Value 2021-2025 ($ Millions)
Figure 107. Brazil Methylphenidate Consumption 2021-2025 (K MT)
Figure 108. Brazil Methylphenidate Value 2021-2025 ($ Millions)
Figure 109. China Methylphenidate Consumption 2021-2025 (K MT)
Figure 110. China Methylphenidate Value 2021-2025 ($ Millions)
Figure 111. Japan Methylphenidate Consumption 2021-2025 (K MT)
Figure 112. Japan Methylphenidate Value 2021-2025 ($ Millions)
Figure 113. Korea Methylphenidate Consumption 2021-2025 (K MT)
Figure 114. Korea Methylphenidate Value 2021-2025 ($ Millions)
Figure 115. Southeast Asia Methylphenidate Consumption 2021-2025 (K MT)
Figure 116. Southeast Asia Methylphenidate Value 2021-2025 ($ Millions)
Figure 117. India Methylphenidate Consumption 2021-2025 (K MT)
Figure 118. India Methylphenidate Value 2021-2025 ($ Millions)
Figure 119. Australia Methylphenidate Consumption 2021-2025 (K MT)
Figure 120. Australia Methylphenidate Value 2021-2025 ($ Millions)
Figure 121. Germany Methylphenidate Consumption 2021-2025 (K MT)
Figure 122. Germany Methylphenidate Value 2021-2025 ($ Millions)
Figure 123. France Methylphenidate Consumption 2021-2025 (K MT)
Figure 124. France Methylphenidate Value 2021-2025 ($ Millions)
Figure 125. UK Methylphenidate Consumption 2021-2025 (K MT)
Figure 126. UK Methylphenidate Value 2021-2025 ($ Millions)
Figure 127. Italy Methylphenidate Consumption 2021-2025 (K MT)
Figure 128. Italy Methylphenidate Value 2021-2025 ($ Millions)
Figure 129. Russia Methylphenidate Consumption 2021-2025 (K MT)
Figure 130. Russia Methylphenidate Value 2021-2025 ($ Millions)
Figure 131. Spain Methylphenidate Consumption 2021-2025 (K MT)
Figure 132. Spain Methylphenidate Value 2021-2025 ($ Millions)
Figure 133. Egypt Methylphenidate Consumption 2021-2025 (K MT)
Figure 134. Egypt Methylphenidate Value 2021-2025 ($ Millions)
Figure 135. South Africa Methylphenidate Consumption 2021-2025 (K MT)
Figure 136. South Africa Methylphenidate Value 2021-2025 ($ Millions)
Figure 137. Israel Methylphenidate Consumption 2021-2025 (K MT)
Figure 138. Israel Methylphenidate Value 2021-2025 ($ Millions)
Figure 139. Turkey Methylphenidate Consumption 2021-2025 (K MT)
Figure 140. Turkey Methylphenidate Value 2021-2025 ($ Millions)
Figure 141. GCC Countries Methylphenidate Consumption 2021-2025 (K MT)
Figure 142. GCC Countries Methylphenidate Value 2021-2025 ($ Millions)
Figure 143. Pfizer Methylphenidate Market Share (2018-2020)
Figure 144. Teva Methylphenidate Market Share (2018-2020)
Figure 145. Sandoz Methylphenidate Market Share (2018-2020)
Figure 146. GSK Methylphenidate Market Share (2018-2020)
Figure 147. Novartis Methylphenidate Market Share (2018-2020)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のメチルフェニデート市場予測 2020年-2025年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆